日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Autologous CD7 CAR-T cells generated without T cell pre-selection in pediatric patients with relapsed/refractory T-ALL: A phase I trial

在复发/难治性T细胞急性淋巴细胞白血病（T-ALL）患儿中，无需T细胞预筛选即可生成的自体CD7 CAR-T细胞：一项I期试验

期刊:Molecular Therapy
影响因子:12
doi:10.1016/j.ymthe.2024.09.006
Zhao, Liping; Li, Chuo; Zuo, Shiyu; Han, Yajing; Deng, Biping; Ling, Zhuojun; Zhang, Yanlei; Peng, Shuixiu; Xu, Jinlong; Duan, Jiajia; Wang, Zelin; Yu, Xinjian; Zheng, Qinlong; Xu, Xiuwen; Yuan, Ying; Tian, Zhenglong; Tang, Kaiting; Zhang, Yibing; Niu, Qing; Zhang, Jiecheng; Chang, Alex H; Luo, Yuechen; Feng, Xiaoming; Pan, Jing
CD7
T细胞
白血病
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Five-year outcome of CD19 followed by CD22 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia patients who relapsed after allo-transplantation

CD19 后序贯 CD22 嵌合抗原受体 T 细胞疗法治疗异基因移植后复发的 B 细胞急性淋巴细胞白血病患者的五年疗效

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2024.286534
Liu, Shuangyou; An, Lihong; Yin, Zhichao; Lin, Yuehui; Ling, Zhuojun; Deng, Biping; Yu, Xinjian; Zheng, Qinlong; Zhao, Defeng; Wu, Tong; Chang, Alex H; Tong, Chunrong
T细胞
信号转导
白血病
CD22
细胞生物学
CD2
CD19
发表日期：2025
文献求助 收藏

Sequential pseudoallogeneic CAR20/22/19 T-cell therapy in patient with diffuse large B-cell lymphoma relapse after allo-HSCT: a case report

异基因造血干细胞移植后弥漫性大B细胞淋巴瘤复发患者序贯假异基因CAR20/22/19 T细胞治疗：病例报告

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1687478
Xiong, Yu; Feng, Shaomei; Liu, Weicheng; Zheng, Qinlong; Deng, Biping; Li, Zhihui; Zhao, Defeng
B细胞
发育与干细胞
T细胞
淋巴瘤
T细胞
干细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

CAR T- cell therapy provides an opportunity for further consolidation treatment for relapsed or refractory adult Burkitt lymphoma patients

CAR-T细胞疗法为复发或难治性成人伯基特淋巴瘤患者提供了进一步巩固治疗的机会。

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1566938
Liu, Rui; Yang, Fan; Ma, Lixia; Guo, Yuelu; Cao, Miaomiao; Fu, Zhonghua; Deng, Biping; Zheng, Qinlong; Chen, Chen; Li, Danyang; Ke, Xiaoyan; Hu, Kai
T细胞
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

CAR-T cell therapy in TP53-mutated CNS lymphoma: overcoming a high-risk genetic barrier

CAR-T细胞疗法治疗TP53突变型中枢神经系统淋巴瘤：克服高风险遗传障碍

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1731589
Li, Danyang; Liu, Rui; Fu, Zhonghua; Yang, Fan; Ma, Lixia; Cao, Miaomiao; Guo, Yuelu; Deng, Biping; Chang, Alex H; Zheng, Qinlong; Ke, Xiaoyan; Hu, Kai
T细胞
淋巴瘤
神经科学
T细胞
P53
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Activity of trametinib as maintenance therapy after allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory RAS pathway-mutated hematologic malignancies

曲美替尼作为异基因造血干细胞移植后维持治疗在复发或难治性RAS通路突变血液系统恶性肿瘤患者中的活性

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-024-06046-7
Li, Zhihui; Yang, Keyan; Xu, Teng; Wang, Lei; Wang, Xianxuan; Wen, Xiaopei; Zhang, Caiyan; Wang, Jingjing; Zheng, Xiaoyu; Wu, Tong; Zheng, Qinlong
肿瘤
发育与干细胞
肿瘤免疫
信号转导
干细胞
细胞生物学
RAS
发表日期：2025
文献求助 收藏

C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial

C-JUN过表达CAR-T细胞治疗急性髓系白血病：临床前表征和I期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-024-50485-9
Zuo, Shiyu; Li, Chuo; Sun, Xiaolei; Deng, Biping; Zhang, Yibing; Han, Yajing; Ling, Zhuojun; Xu, Jinlong; Duan, Jiajia; Wang, Zelin; Yu, Xinjian; Zheng, Qinlong; Xu, Xiuwen; Zong, Jiao; Tian, Zhenglong; Shan, Lingling; Tang, Kaiting; Huang, Huifang; Song, Yanzhi; Niu, Qing; Zhou, Dongming; Feng, Sizhou; Han, Zhongchao; Wang, Guoling; Wu, Tong; Pan, Jing; Feng, Xiaoming
T细胞
白血病
T细胞
JUN
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Identifying risk factors for severe omicron infection in allogeneic hematopoietic stem cell transplant recipients with hematologic malignancies

识别异基因造血干细胞移植受者合并血液系统恶性肿瘤发生严重奥密克戎感染的危险因素

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.2103
Li, Zhihui; Wang, Lei; Zheng, Qinlong; Xu, Teng; Yang, Keyan; Wang, Xianxuan; Wen, Xiaopei; Zhang, Caiyan; Wang, Jingjing; Song, Yanzhi; Zhao, Yongqiang; Zheng, Xiaoyu; Wu, Tong
肿瘤
肿瘤免疫
细胞生物学
炎症/感染
干细胞
发育与干细胞
发表日期：2024
文献求助 收藏

Long-term follow-up of donor-derived CD7 CAR T-cell therapy in patients with T-cell acute lymphoblastic leukemia

对接受供体来源 CD7 CAR T 细胞疗法治疗 T 细胞急性淋巴细胞白血病患者进行长期随访

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/s13045-023-01427-3
Tan, Yue; Shan, Lingling; Zhao, Liping; Deng, Biping; Ling, Zhuojun; Zhang, Yanlei; Peng, Shuixiu; Xu, Jinlong; Duan, Jiajia; Wang, Zelin; Yu, Xinjian; Zheng, Qinlong; Xu, Xiuwen; Tian, Zhenglong; Zhang, Yibing; Zhang, Jiecheng; Chang, Alex H; Feng, Xiaoming; Pan, Jing
白血病
细胞生物学
CD7
T细胞
发表日期：2023
文献求助 收藏

Genetic landscapes and curative effect of CAR T-cell immunotherapy in patients with relapsed or refractory DLBCL

遗传图谱及CAR-T细胞免疫疗法对复发或难治性弥漫性大B细胞淋巴瘤患者的疗效

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021006845
Shi, Hui; Zheng, Peihao; Liu, Rui; Xu, Teng; Yang, Fan; Feng, Shaomei; Guo, Yuelu; Ma, Lixia; Liu, Haidi; Lei, Yang; Li, Ruiting; Deng, Biping; Hou, Shuling; Li, Yang; Zheng, Qinlong; Hu, Kai; Ke, Xiaoyan
B细胞
细胞生物学
T细胞
免疫/内分泌
淋巴瘤
T细胞
发表日期：2023
文献求助 收藏